Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Pudekangli Pharmaceutical Technology Development is a specialized pharmaceutical research and development organization headquartered in Beijing, China. Founded in 2002, the company provides a wide range of services including chemical drug synthesis, formulation development, and generic drug consistency evaluation. It operates primarily as a Contract Research Organization (CRO) and technology transfer partner, assisting pharmaceutical manufacturers in navigating the regulatory landscape and improving drug quality. The firm has established a strong reputation in the Chinese market for its expertise in complex generics and technical support for clinical bioequivalence studies. Pudekangli serves as a key technical partner for numerous domestic pharmaceutical companies, facilitating the modernization and regulatory compliance of their product portfolios.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Pudekangli Pharmaceutical Technology Development.